v3.22.2
Consolidated Balance Sheets - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Current Assets    
Cash $ 45,877 $ 95,172
Accounts receivable 13,500
Patient financing receivable, current portion 40,299 43,900
Prepaid expenses 136,998 44,884
Total Current Assets 223,174 197,456
Property and equipment, net 23,641 38,374
Patient financing receivable, net of current portion 40,464 67,163
Other assets 18,412 18,412
Total assets 305,691 321,405
Current Liabilities    
Accounts payable 699,358 585,291
Accrued liabilities 135,601 164,680
Other current liabilities 116,341 28,246
Notes payable, current portion 84,455 69,455
Convertible notes payable, related parties 1,969,174 1,969,174
Convertible notes payable 1,715,911 1,355,826
PPP Loan, current portion 66,275
Deferred revenue 414,025
Lease liability, current portion 99,369 94,805
Interest payable, related parties 200,371 98,055
Interest payable 155,138 75,048
Total Current Liabilities 5,175,718 4,920,880
Long-term Liabilities    
Royalty obligation (see note 4) 1,697,000
Lease liability, net of current portion 12,249 62,768
Total Long-term Liabilities 1,709,249 62,768
Total Liabilities 6,884,967 4,983,648
Stockholders’ Equity (Deficit)    
Preferred Stock - $.001 par value: 1,000,000,000 shares authorized; Series A Preferred Stock - $.001 par value: 800,000,000 shares authorized, 494,579,119 and 501,887,534 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively. 494,578 501,887
Common stock - $.001 par value: 500,000,000 shares authorized, 257,282 and 166,394 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively. [1] 257 164,199
Additional paid-in capital [1] 48,481,350 43,700,084
Accumulated deficit (55,555,461) (49,028,413)
Total Stockholders’ Deficit (6,579,276) (4,662,243)
Total Liabilities and Stockholders’ Deficit $ 305,691 $ 321,405
[1] The number of outstanding shares of common stock have been adjusted for all periods presented to reflect a one-for-one thousand reverse stock split that became effective on June 13, 2022. The amounts in common stock and additional paid-in capital were adjusted as of the effective date of the one-for-one thousand reverse stock split. See Note 1 for additional information.

Source